查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1556576

介入性肿瘤消融市场报告：2030 年趋势、预测与竞争分析

Interventional Oncology Ablation Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

介入性肿瘤消融趋势与预测

预计到 2030 年，全球介入性肿瘤消融市场预计将达到 9.079 亿美元，2024 年至 2030 年复合年增长率为 8.2%。该市场的主要驱动力是癌症盛行率的上升和消融意识的提高。全球介入性肿瘤消融市场未来性，医院和诊所市场以及门诊手术中心市场充满机会。

按细分市场分類的介入性肿瘤消融趋势

本研究按技术、适应症、最终用途和地区对全球介入性肿瘤消融进行预测。

介入性肿瘤消融市场洞察

Lucintel 预测，在预测期内，肺癌仍将是最大的细分市场。

在预测期内，医院和诊所将继续成为该市场的重要组成部分。

在预测期内，北美仍然是最大的地区。

常问问题

Q1.市场规模为：

A1. 至2030年，全球介入性肿瘤消融市场预计将达到9.079亿美元。

Q2.市场成长预测是多少：

A2.预计2024年至2030年全球介入性肿瘤消融市场将以8.2%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是癌症盛行率的上升和消融意识的提高。

Q4.市场的主要细分市场是：

A4. 介入性肿瘤消融市场前景广阔，医院/诊所市场和门诊手术中心市场充满机会。

Q5.市场的主要企业是：

A5.介入性肿瘤消融的主要企业有：

  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic
  • Varian Medical Systems
  • EDAP TMS
  • AngioDynamics
  • CASCINATION
  • Merit Medical Systems
  • STARmed
  • Biomedical

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计肺癌在预测期内仍将是其最大的细分市场。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 在预测期内，北美仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球介入性肿瘤消融市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球介入性肿瘤消融市场趋势（2018-2023）与预测（2024-2030）
  • 按技术分類的全球介入性肿瘤消融市场
    • 射频消融术
    • 微波消融
    • 冷冻疗法
    • 不可逆电穿孔消融
  • 按适应症分類的全球介入性肿瘤消融市场
    • 肝癌
    • 肾癌
    • 肺癌
    • 其他的
  • 按最终用途分類的全球介入性肿瘤消融市场
    • 医院/诊所
    • 门诊手术中心
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球介入性肿瘤消融市场区域分布
  • 北美介入性肿瘤消融市场
  • 欧洲介入性肿瘤消融市场
  • 亚太介入肿瘤消融市场
  • 其他区域介入肿瘤消融市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球介入性肿瘤消融市场技术成长机会
    • 全球介入性肿瘤消融市场成长机会（按适应症）
    • 全球介入性肿瘤消融市场成长机会（依最终用途）
    • 全球介入性肿瘤消融市场按地区成长机会
  • 全球介入性肿瘤消融市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球介入性肿瘤消融市场产能扩张
    • 全球介入性肿瘤消融市场的併购与合资
    • 认证和许可

第七章主要企业概况

  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic
  • Varian Medical Systems
  • EDAP TMS
  • AngioDynamics
  • CASCINATION
  • Merit Medical Systems
  • STARmed
  • Biomedical
简介目录

Interventional Oncology Ablation Trends and Forecast

The future of the global interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets. The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Interventional Oncology Ablation by Segment

The study includes a forecast for the global interventional oncology ablation by technology, indication, end use, and region.

Interventional Oncology Ablation Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation

Interventional Oncology Ablation Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Others

Interventional Oncology Ablation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Interventional Oncology Ablation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Interventional Oncology Ablation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies interventional oncology ablation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the interventional oncology ablation companies profiled in this report include-

  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic
  • Varian Medical Systems
  • EDAP TMS
  • AngioDynamics
  • CASCINATION
  • Merit Medical Systems
  • STARmed
  • Biomedical

Interventional Oncology Ablation Market Insights

Lucintel forecasts that lung will remain the largest segment over the forecast period.

Within this market, hospital & clinic will remain larger segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Interventional Oncology Ablation Market

Market Size Estimates: Interventional oncology ablation market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Interventional oncology ablation market size by technology, indication, end use, and region in terms of value ($M).

Regional Analysis: Interventional oncology ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, indications, end uses, and regions for the interventional oncology ablation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the interventional oncology ablation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the interventional oncology ablation market size?

Answer: The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030.

Q2. What is the growth forecast for interventional oncology ablation market?

Answer: The global interventional oncology ablation market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the interventional oncology ablation market?

Answer: The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.

Q4. What are the major segments for interventional oncology ablation market?

Answer: The future of the interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets.

Q5. Who are the key interventional oncology ablation market companies?

Answer: Some of the key interventional oncology ablation companies are as follows:

  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic
  • Varian Medical Systems
  • EDAP TMS
  • AngioDynamics
  • CASCINATION
  • Merit Medical Systems
  • STARmed
  • Biomedical

Q6. Which interventional oncology ablation market segment will be the largest in future?

Answer: Lucintel forecasts that lung will remain the largest segment over the forecast period.

Q7. In interventional oncology ablation market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the interventional oncology ablation market by technology (radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation ablation), indication (liver cancer, kidney cancer, lung cancer, and others), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Interventional Oncology Ablation Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Interventional Oncology Ablation Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Interventional Oncology Ablation Market by Technology
    • 3.3.1: Radiofrequency Ablation
    • 3.3.2: Microwave Ablation
    • 3.3.3: Cryoablation
    • 3.3.4: Irreversible Electroporation Ablation
  • 3.4: Global Interventional Oncology Ablation Market by Indication
    • 3.4.1: Liver Cancer
    • 3.4.2: Kidney Cancer
    • 3.4.3: Lung Cancer
    • 3.4.4: Others
  • 3.5: Global Interventional Oncology Ablation Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Ambulatory Surgical Centers
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Interventional Oncology Ablation Market by Region
  • 4.2: North American Interventional Oncology Ablation Market
    • 4.2.1: North American Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
    • 4.2.2: North American Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.3: European Interventional Oncology Ablation Market
    • 4.3.1: European Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
    • 4.3.2: European Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Interventional Oncology Ablation Market
    • 4.4.1: APAC Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
    • 4.4.2: APAC Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Interventional Oncology Ablation Market
    • 4.5.1: ROW Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
    • 4.5.2: ROW Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Interventional Oncology Ablation Market by Technology
    • 6.1.2: Growth Opportunities for the Global Interventional Oncology Ablation Market by Indication
    • 6.1.3: Growth Opportunities for the Global Interventional Oncology Ablation Market by End Use
    • 6.1.4: Growth Opportunities for the Global Interventional Oncology Ablation Market by Region
  • 6.2: Emerging Trends in the Global Interventional Oncology Ablation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Interventional Oncology Ablation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Interventional Oncology Ablation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Boston Scientific Corporation
  • 7.2: Johnson & Johnson
  • 7.3: Medtronic
  • 7.4: Varian Medical Systems
  • 7.5: EDAP TMS
  • 7.6: AngioDynamics
  • 7.7: CASCINATION
  • 7.8: Merit Medical Systems
  • 7.9: STARmed
  • 7.10: Biomedical